血清miR-155-5p和miR-146b-5p与继发性急性髓系白血病染色体畸变及预后的关系

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1843 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the relationship between serum microRNA(miR-155-5p) and miR-146b-5p and chromosome aberration and prognosis of secondary acute myeloid leukemia (sAML). Methods A total of 26 patients with sAML who were treated in the Department of Hematology of the Second the Second Hospital affiliated to Medical University of PLA Air Force from May 2017 to April 2020 were selected, and 25 healthy people who underwent physical examination in the hospital during the same period were included as healthy control group. According to International System for Human Cytogenetic Nomenclature, sAML patients were divided into chromosome aberrant group and chromosome normal group. The serum levels of miR-155-5p and miR-146b-5p were detected by real-time fluorescence quantitative PCR, and the overall survival of patients during follow-up was recorded. Results Compared with the healthy control group, serum miR-155-5p significantly increased[4.69(1.87,30.83) vs. 1.13(0.79,1.78), Z=-4.070,P＜0.001] and miR-146b-5p significantly decreased [1.79(1.55,2.44) vs. 3.02(2.58,3.43), Z=-4.561, P＜0.001]in the sAML group. The area under the curve of serum miR-155-5p and miR-146b-5p combined diagnosis of sAML was 0.922 (95%CI: 0.846~0.997).Compared with the normal group, the serum miR-155-5p significantly increased [19.26(4.45,46.65) vs. 1.51(0.79,3.27), Z=-3.585,P＜0.001]and miR-146b-5p significantly decreased [1.55(1.50,1.97) vs. 2.16(1.79,3.00), Z=-2.954, P=0.003]in the chromosomal aberration group. The AUC of serum miR-155-5p and miR-146b-5p levels to identify chromosome aberrations was 0.925 (95%CI: 0.826~1.000),0.850(95%CI: 0.703~0.997), and the combined AUC increased to 0.919(95%CI: 0.812~1.000). Multivariate Logistic regression analysis showed that serum miR-155-5p and miR-146b-5p levels were independent influencing factors of chromosome aberration (P＜0.05). Patients with high miR-155-5p expression (≥4.27) and low miR-146b-5p expression (＜1.62) had lower overall survival rate and shorter median survival time (P＜0.05). Cox regression analysis showed that high expression of miR-155-5p and low expression of miR-146b-5p in serum were independent risk factors for death in sAML patients (P＜0.05). Conclusions The high expression of miR-155-5p and the low expression of miR-146b-5p in serum are closely related to chromosome aberration and poor prognosis in sAML patients, and they may be risk predictors of chromosome aberration and poor prognosisof sAML patients.

Key words： miR-155-5p miR-146b-5p secondary acute myeloid leukemia chromosome aberration prognosis

Received: 17 July 2023

ZTFLH:

R733.71

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YAN Xueqian
	LIU Li
	JI Yueru
	QIN Weiwei
	XIAO Fang
	CHEN Yi

Cite this article:

YAN Xueqian,LIU Li,JI Yueru等. Relationship between serum miR-155-5p and miR-146b-5p and chromosome aberration and prognosis of secondary acute myeloid leukemia[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2024, 35(1): 14-20.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2024/V35/I1/14

[4]	Higgins A, Shah M V. Genetic and genomic landscape of secondary and therapy-related acute myeloid leukemia[J]. Genes, 2020, 11(7): 749-772.
[1]	Lalayanni C, Gavriilaki E, Athanasiadou A, et al. Secondary acute myeloid leukemia (sAML): similarly dismal outcomes of AML after an antecedent hematologic disorder and therapy related AML?[J].Clin Lymphoma Myeloma Leuk, 2022, 22(4):e233-e240.
[5]	张华,王宏利. 儿童急性淋巴细胞白血病相关的循环微RNAs研究进展[J]. 中国新药与临床杂志,2022,41(3):134-137.
[2]	马玲,赵婷,陈育红,等. 继发性急性髓系白血病的治疗反应和结局及其影响因素分析[J]. 中华血液学杂志,2023,44(2):124-131.
[6]	Bauer M, Vaxevanis C, Heimer N, et al. Expression, regulation and function of microRNA as important players in the transition of MDS to secondary AML and their cross talk to RNA-binding proteins[J]. Int J Mol SCI, 2020, 21(19): 7140-7168.
[3]	Yamaguchi H.Importance of gene mutation analysis as prognostic factor of acute myeloid leukemia[J]. Rinsho Ketsueki, 2020, 61(9):1160-1165.
[7]	靳睿哲,王迪娴,赵乾,等. miR-155-5p在肿瘤中的表达、功能以及调控作用[J]. 肿瘤防治研究,2023,50(3):309-315.
[4]	Higgins A, Shah M V. Genetic and genomic landscape of secondary and therapy-related acute myeloid leukemia[J]. Genes, 2020, 11(7): 749-772.
[8]	Sun X, Guan G, Dai Y, et al. microRNA-155-5p initiates childhood acute lymphoblastic leukemia by regulating the IRF4/CDK6/CBL axis[J].Lab Invest, 2022, 102(4):411-421.
[5]	张华,王宏利. 儿童急性淋巴细胞白血病相关的循环微RNAs研究进展[J]. 中国新药与临床杂志,2022,41(3):134-137.
[9]	Shi L, Su Y, Zheng Z, et al. miR-146b-5p promotes colorectal cancer progression by targeting TRAF6[J].Exp Ther Med, 2022, 23(3):231-241.
[6]	Bauer M, Vaxevanis C, Heimer N, et al. Expression, regulation and function of microRNA as important players in the transition of MDS to secondary AML and their cross talk to RNA-binding proteins[J]. Int J Mol SCI, 2020, 21(19): 7140-7168.
[10]	王娜,龚莉莉,叶春梅. miR-146b-5p靶向ZNRF2影响IL-17a诱导乳腺癌细胞增殖、迁移和侵袭[J]. 中国免疫学杂志,2021,37(14):1738-1743.
[7]	靳睿哲,王迪娴,赵乾,等. miR-155-5p在肿瘤中的表达、功能以及调控作用[J]. 肿瘤防治研究,2023,50(3):309-315.
[11]	Tu Z, Xiong J, Xiao R, et al. Loss of miR-146b-5p promotes T cell acute lymphoblastic leukemia migration and invasion via the IL-17A pathway[J].J Cell Biochem, 2019, 120(4):5936-5948.
[8]	Sun X, Guan G, Dai Y, et al. microRNA-155-5p initiates childhood acute lymphoblastic leukemia by regulating the IRF4/CDK6/CBL axis[J].Lab Invest, 2022, 102(4):411-421.
[12]	Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J].Blood, 2016, 127(20):2391-2405.
[9]	Shi L, Su Y, Zheng Z, et al. miR-146b-5p promotes colorectal cancer progression by targeting TRAF6[J].Exp Ther Med, 2022, 23(3):231-241.
[13]	ISCN 2020. An international system for human cytogenomic nomenclature (2020)[J]. Cytogenet Genome Res, 2020, 160(7-8): 341-503.
[10]	王娜,龚莉莉,叶春梅. miR-146b-5p靶向ZNRF2影响IL-17a诱导乳腺癌细胞增殖、迁移和侵袭[J]. 中国免疫学杂志,2021,37(14):1738-1743.
[14]	Chen A, Wen J, Lu C, et al. Inhibition of miR1555p attenuates the valvular damage induced by rheumatic heart disease[J]. Int J mol med, 2020, 45(2): 429-440.
[11]	Tu Z, Xiong J, Xiao R, et al. Loss of miR-146b-5p promotes T cell acute lymphoblastic leukemia migration and invasion via the IL-17A pathway[J].J Cell Biochem, 2019, 120(4):5936-5948.
[15]	Liang C, Li Y, Wang L N, et al. Up-regulated miR-155 is assoCIated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238[J].Hematology, 2021, 26(1):16-25.
[12]	Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J].Blood, 2016, 127(20):2391-2405.
[16]	Soltani I, Bahia W, Farrah A, et al. Potential functions of hsa-miR-155-5p and core genes in chronic myeloid leukemia and emerging role in human cancer: a joint bioinformatics analysis[J].Genomics, 2021, 113(4):1647-1658.
[13]	ISCN 2020. An international system for human cytogenomic nomenclature (2020)[J]. Cytogenet Genome Res, 2020, 160(7-8): 341-503.
[17]	Xu W D, Feng S Y, Huang A F. Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review[J]. Inflammation Research, 2022, 71(12): 1501-1517.
[14]	Chen A, Wen J, Lu C, et al. Inhibition of miR1555p attenuates the valvular damage induced by rheumatic heart disease[J]. Int J mol med, 2020, 45(2): 429-440.
[18]	Pagotto S, Veronese A, Soranno A, et al. HNRNPL restrains miR-155 targeting of BUB1 to stabilize aberrant karyotypes of transformed cells in chronic lymphocytic leukemia[J].Cancers (Basel), 2019, 11(4):575-590.
[15]	Liang C, Li Y, Wang L N, et al. Up-regulated miR-155 is assoCIated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238[J].Hematology, 2021, 26(1):16-25.
[19]	Luo Y Y, Wang Z H, Yu Q, et al. LncRNA-NEAT1 promotes proliferation of T-ALL cells via miR-146b-5p/NOTCH1 signaling pathway[J].Pathol Res Pract, 2020, 216(11):153212-153218.
[16]	Soltani I, Bahia W, Farrah A, et al. Potential functions of hsa-miR-155-5p and core genes in chronic myeloid leukemia and emerging role in human cancer: a joint bioinformatics analysis[J].Genomics, 2021, 113(4):1647-1658.
[20]	Láinez-González D, Serrano-López J, Alonso-Dominguez J M. Understanding the notch signaling pathway in acute myeloid leukemia stem cells: from hematopoiesis to neoplasia[J].Cancers (Basel), 2022, 14(6):1459-1467.
[17]	Xu W D, Feng S Y, Huang A F. Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review[J]. Inflammation Research, 2022, 71(12): 1501-1517.
[21]	Choi Y, Hur E H, Moon J H, et al. Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome[J].Korean J Intern Med, 2019, 34(2):390-400.
[18]	Pagotto S, Veronese A, Soranno A, et al. HNRNPL restrains miR-155 targeting of BUB1 to stabilize aberrant karyotypes of transformed cells in chronic lymphocytic leukemia[J].Cancers (Basel), 2019, 11(4):575-590.
[22]	Matis S, Grazia Recchia A, Colombo M, et al. MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells[J].Blood Adv, 2022, 6(20):5593-5612.
[19]	Luo Y Y, Wang Z H, Yu Q, et al. LncRNA-NEAT1 promotes proliferation of T-ALL cells via miR-146b-5p/NOTCH1 signaling pathway[J].Pathol Res Pract, 2020, 216(11):153212-153218.
[23]	Cai B, Liu Y, Chong Y, et al. IRAK1-regulated IFN-γ signaling induces MDSC to faCIlitate immune evasion in FGFR1-driven hematological malignanCIes[J].Mol Cancer, 2021, 20(1):165-183
[20]	Láinez-González D, Serrano-López J, Alonso-Dominguez J M. Understanding the notch signaling pathway in acute myeloid leukemia stem cells: from hematopoiesis to neoplasia[J].Cancers (Basel), 2022, 14(6):1459-1467.
[24]	Gębarowska K, Mroczek A, Kowalczyk J R, et al. MicroRNA as a prognostic and diagnostic marker in T-cell acute lymphoblastic leukemia[J]. Int J Mol SCI, 2021, 22(10): 5317-5330.
[21]	Choi Y, Hur E H, Moon J H, et al. Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome[J].Korean J Intern Med, 2019, 34(2):390-400.
[22]	Matis S, Grazia Recchia A, Colombo M, et al. MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells[J].Blood Adv, 2022, 6(20):5593-5612.
[23]	Cai B, Liu Y, Chong Y, et al. IRAK1-regulated IFN-γ signaling induces MDSC to faCIlitate immune evasion in FGFR1-driven hematological malignanCIes[J].Mol Cancer, 2021, 20(1):165-183
[24]	Gębarowska K, Mroczek A, Kowalczyk J R, et al. MicroRNA as a prognostic and diagnostic marker in T-cell acute lymphoblastic leukemia[J]. Int J Mol SCI, 2021, 22(10): 5317-5330.

[1]	. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2024, 35(5): 439-442.